Publication:
DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO

Simple item page
dc.contributor.authorDİRESKENELİ, RAFİ HANER
dc.contributor.authorYAVUZ, SUAT
dc.contributor.authorsInel, T. Yuce; Kocaer, S. B.; Erez, Y.; Gulle, S.; Karakas, A.; Avsar, A. Koken; Uslu, S.; Can, G.; Sari, I.; Birlik, M.; Dalkilic, E.; Pehlivan, Y.; Akar, S.; Goker, B.; Cetin, G. Yildirim; Haznedaroglu, S.; Yavuz, S.; Pirildar, T.; Direskeneli, H.; Akkoc, N.; Onen, F.
dc.date.accessioned2022-03-12T16:24:46Z
dc.date.accessioned2026-01-10T19:36:04Z
dc.date.available2022-03-12T16:24:46Z
dc.date.issued2020
dc.identifier.doi10.1136/annrheumdis-2020-eular.1599
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/226447
dc.identifier.wosWOS:000555905003171
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage978
oaire.citation.startPage978
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume79

Files

Collections

Araştırma Çıktıları